Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pre-mRNA-splicing factor 18 (PRPF18) is an essential spliceosomal protein required for the second catalytic step of pre-mRNA splicing, a process fundamental to the maturation of messenger RNA in eukaryotes[2][3][4][7]. It is a WD-repeat protein closely related to the yeast splicing factor Prp18, and is tightly bound to the spliceosome during the second step of splicing[2][5]. PRPF18 participates in critical steps of mRNA processing; mutations or disruptions in this gene have been associated with rare genetic disorders involving neurodevelopment and retinal degeneration[3]. It is not currently considered a direct therapeutic target, nor are there drugs known to act specifically on PRPF18.
Not applicable (no known drug interactions)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pre-mRNA-splicing factor 18 (PRPF18).